US11721435B2 - Automated quality assessment of physiological signals - Google Patents
Automated quality assessment of physiological signals Download PDFInfo
- Publication number
- US11721435B2 US11721435B2 US16/418,352 US201916418352A US11721435B2 US 11721435 B2 US11721435 B2 US 11721435B2 US 201916418352 A US201916418352 A US 201916418352A US 11721435 B2 US11721435 B2 US 11721435B2
- Authority
- US
- United States
- Prior art keywords
- noise
- physiological signal
- noise source
- signal data
- source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/486—Biofeedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
- A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7221—Determining signal validity, reliability or quality
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N5/00—Computing arrangements using knowledge-based models
- G06N5/04—Inference or reasoning models
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
Definitions
- Embodiments generally relate to health monitoring. More particularly, embodiments relate to the automated quality assessment of physiological signals in home health monitoring settings.
- Health monitoring may traditionally involve obtaining physiological signals such as electrocardiogram (ECG) readings from an individual in a clinical setting such as a hospital, doctor's office or other medical center.
- ECG electrocardiogram
- a medical professional may connect various sensors to the individual/patient and interpret the readings in order to make health-related decisions. If the medical professional determines that the ECG readings are not reliable or of adequate quality, the medical professional may make adjustments to the sensing configuration and/or environment prior to making health-related decisions based on those readings.
- patients may often lack the requisite medical and/or technical knowledge to identify unreliable or inferior quality readings and make the appropriate adjustments to the sensing configuration/environment.
- suboptimal health care e.g., improper diagnosis, increased cost and/or increased patient risk
- FIG. 1 is an illustration of an example of a set of signals according to an embodiment
- FIGS. 2 A and 2 B are illustrations of examples of sensing configurations according embodiments
- FIG. 3 is a flowchart of an example of a method of evaluating physiological signals according to an embodiment
- FIG. 4 is a plot of an example of a weighting approach according to an embodiment
- FIG. 5 is a block diagram of an example of a logic architecture according to an embodiment.
- FIG. 6 is a block diagram of an example of a platform according to an embodiment.
- FIG. 1 shows a plurality of signals that may be associated with the monitoring of an individual/patient in a home health setting.
- a physiological signal 10 such as, for example, an electrocardiogram (ECG) signal may be deemed reliable due to a lack of noise in the physiological signal 10 .
- ECG electrocardiogram
- the physiological signal 10 may contain blood pressure information, pulse oximeter information, Electroencephalograph (EEG) information, Photoplethysmograph (PPG) information, and so forth.
- ECG Electroencephalograph
- PPG Photoplethysmograph
- a plurality of noise sources 12 may be superimposed on physiological signals such as the signal 10 and therefore reduce the quality and/or reliability of those signals.
- a power main (e.g., 50/60 Hz) interference source 12 a might originate from nearby low frequency electrical equipment, building power lines, etc.
- a muscle noise source 12 b may originate from involuntary muscle contractions of the patient due to anxiety, and a motion artifact noise source 12 c may originate from patient movement.
- an electromagnetic interference (EMI) source 12 d may originate from nearby high frequency devices such as mobile phones and other electronic devices, and a baseline wander noise source 12 e may originate from chemical reactions and other contributors to changes in skin-electrode impedance.
- EMI electromagnetic interference
- Each of the noise sources 12 may therefore have a negative impact on the quality of the measured physiological signal to the extent that the respective type of noise is present in the physiological signal.
- the noise sources 12 may present unique challenges in home health settings due to a relative lack of medical and/or technical knowledge of typical patients.
- both a qualitative analysis and a quantitative analysis may be conducted in home health settings for each of the noise sources 12 , wherein those analyses may be used to determine whether and when to report the physiological signals to a remote location such as a clinical health setting (e.g., hospital, doctor's office or other medical center).
- a clinical health setting e.g., hospital, doctor's office or other medical center.
- the analyses may be used to guide patients in modifying the sensor configuration and/or environment in order to increase the reliability of reported physiological signals.
- FIG. 2 A a home health monitoring environment is shown in which a patient 14 uses a mobile device 16 to take readings such as, for example, ECG readings, blood pressure readings, pulse oximeter readings, EEG readings, PPG readings, and so forth.
- the mobile device 16 includes one or more sensors (e.g., electrodes, contacts) 18 that may be pressed against a body part (e.g., chest, arm, head) of the patient 14 in order to measure the physiological condition of the patient 14 .
- the mobile device 16 may generate one or more physiological signals in conjunction with the readings, wherein the physiological signals may be transmitted to a healthcare network 20 .
- the mobile device 16 may be configured to make automated quality assessments of the physiological signals prior to transmitting them to the healthcare network 20 as well as guide the patient 14 in taking additional readings if the assessments indicate that earlier readings lack reliability.
- the healthcare network 20 may in turn provide the reported physiological signals to healthcare professionals such as physicians, nurses, clinicians, and so forth. Additionally, the healthcare professionals may deliver advice to the patient 14 via the healthcare network 20 and/or mobile device 16 .
- the mobile device 16 may be a computing platform such as a wireless smart phone, smart tablet, personal digital assistant (PDA), mobile Internet device (MID), notebook computer, convertible tablet, etc., having other functionality such as messaging (e.g., text messaging, instant messaging/IM, email), computing, media playing, and so forth.
- FIG. 2 B shows a home health monitoring environment in which the patient 14 uses a measurement accessory 21 and a mobile device 22 to take readings such as, for example, ECG readings, blood pressure readings, pulse oximeter readings, EEG readings, PPG readings, and so forth.
- the measurement accessory 21 includes one or more sensors (e.g., electrodes, contacts) 24 that may be pressed against a body part of the patient 14 in order to measure the physiological condition of the patient 14 .
- the illustrated measurement accessory 21 generates one or more physiological signals in conjunction with the readings, wherein the physiological signals may be transmitted to the mobile device 22 .
- the measurement accessory 21 or mobile device 22 may be configured to make automated quality assessments of the physiological signals prior to transmitting them to the healthcare network 20 as well as guide the patient 14 in taking additional readings if the assessments indicate that earlier readings lack reliability.
- the healthcare network 20 may provide the reported physiological signals to healthcare professionals, who may deliver advice to the patient 14 via the healthcare network 20 and/or mobile device 22 .
- the mobile device 22 may be a computing platform such as a wireless smart phone, smart tablet, PDA, MID, notebook computer, convertible tablet, etc., with messaging, computing, media playing and/or other functionality.
- FIG. 3 shows a method 26 of evaluating physiological signals in a home health setting.
- the method 26 may be implemented in executable software as a set of logic instructions stored in a machine- or computer-readable medium of a memory such as random access memory (RAM), read only memory (ROM), programmable ROM (PROM), firmware, flash memory, etc., in configurable logic such as, for example, programmable logic arrays (PLAs), field programmable gate arrays (FPGAs), complex programmable logic devices (CPLDs), in fixed-functionality logic hardware using circuit technology such as, for example, application specific integrated circuit (ASIC), complementary metal oxide semiconductor (CMOS) or transistor-transistor logic (TTL) technology, or any combination thereof.
- PLAs programmable logic arrays
- FPGAs field programmable gate arrays
- CPLDs complex programmable logic devices
- ASIC application specific integrated circuit
- CMOS complementary metal oxide semiconductor
- TTL transistor-transistor logic
- computer program code to carry out operations shown in method 26 may be written in any combination of one or more programming languages, including an object oriented programming language such as Java, Smalltalk, C++ or the like and conventional procedural programming languages, such as the “C” programming language or similar programming languages.
- object oriented programming language such as Java, Smalltalk, C++ or the like
- conventional procedural programming languages such as the “C” programming language or similar programming languages.
- Illustrated processing block 28 provides for receiving a physiological signal from a sensor configuration associated with a mobile device.
- the physiological signal may be associated with an ECG reading, blood pressure reading, pulse oximeter reading, EEG reading, PPG reading, and so forth.
- the signal strength of the physiological signal may be estimated at block 30 .
- estimation of the signal strength involves de-noising the physiological signal using multi-band filters.
- the filters used in the de-noising procedure may take into consideration the frequency profile of various types of noise sources (e.g., power main interference, muscle noise, motion artifact noise, EMI, baseline wander noise).
- block 30 may involve signal processing to identify one or more fiducial points in the filtered signal.
- a fudicial point in an ECG signal may correspond to an R-wave (i.e., upward deflection in a QRS complex) of the ECG signal.
- the fiducial points may be used to calculate the signal strength of the physiological signal.
- Block 32 may extract a first noise source from the physiological signal.
- block 32 may apply a digital low pass filter (LPF) having a cutoff frequency of 1 Hz, a cubic spline, etc., to the physiological signal.
- LPF digital low pass filter
- the de-noised physiological signal from block 30 may be subtracted from the signal in block 32 in order to isolate the baseline wander noise 12 e from the physiological signal.
- the output of block 32 may be only the baseline wander, extracted from the physiological signal.
- Illustrated block 34 provides for performing noise estimation for the first noise source. For example, for the baseline wander noise 12 e ( FIG.
- the noise estimation may involve rejecting outlier data in the isolated baseline wander noise and determining/calculating the area under the resulting curve.
- the area under the noise curve may be particularly effective for low frequency noise such as baseline wander noise.
- Block 34 may also provide for normalizing the estimated noise with respect to the physiological signal strength estimated in block 30 .
- a qualitative analysis may be conducted for the first noise source at block 36 . More particularly, an individual qualitative rating—QR 1 (e.g., “Good”, “Fair”, “Poor”) may be assigned to the first noise source by comparing the estimated noise for the first noise source to appropriate thresholds.
- QR 1 an individual qualitative rating
- the qualitative thresholds may be chosen to match manual visual acuity/assessments.
- the rating criteria might be implemented as given in Table I below.
- Illustrated block 38 conducts a quantitative analysis for the first noise source. More particularly, a signal to noise ratio (SNR 1 ) may be computed for the first noise source based on the estimated physiological signal strength from block 30 and the estimated and normalized noise from block 34 . As will be discussed in greater detail, the SNR 1 for the first noise source may be subsequently combined with the SNRs of the other noise sources to obtain an overall quality level for the physiological signal.
- SNR 1 signal to noise ratio
- block 40 may extract a second noise source from the physiological signal.
- block 40 may apply a digital elliptic band pass filter (BPF) having a center frequency of 50 Hz or 60 Hz, a wavelet transform, etc., to the physiological signal.
- BPF digital elliptic band pass filter
- the de-noised physiological signal from block 30 may be subtracted from the filtered signal in block 40 in order to isolate the power main interference source from the physiological signal.
- the output of block 40 may be only the mains 50 or 60 Hz noise, extracted from the physiological signal.
- Illustrated block 42 provides for performing noise estimation for the second noise source. For example, for the power main interference source 12 a ( FIG.
- the noise estimation may involve calculating the peak-to-peak average for the noise curve for the isolated power main interference.
- the peak-to-peak average may be particularly effective for high frequency noise such as power main interference.
- Block 42 may also provide for normalizing the estimated noise with respect to the physiological signal strength estimated in block 30 .
- a qualitative analysis may be conducted for the second noise source at block 44 .
- an individual qualitative rating—QR 2 e.g., “Good”, “Fair”, “Poor”
- QR 2 an individual qualitative rating
- Illustrated block 46 conducts a quantitative analysis for the second noise source. More particularly, an SNR 2 may be computed for the second noise source based on the estimated physiological signal strength from block 30 and the estimated and normalized noise from block 42 .
- the illustrated noise extraction and estimation procedure may be conducted for each of a plurality of noise sources in the physiological signal.
- the noise extraction may involve applying a digital BPF having a center frequency of 2 Hz or 100 Hz to the physiological signal.
- the noise extraction might involve applying a digital notch filter with a center frequency of 50 Hz or 60 Hz to remove power main interference and applying a digital LPF having a cutoff frequency of 5 Hz, a cubic spline, etc.
- Noise extraction techniques may be similarly tailored to the EMI source 12 d ( FIG. 1 ) and other types of noise in the physiological signal.
- the de-noised physiological signal from block 30 may be subtracted from the filtered noise signal in order to isolate the particular type of noise from the physiological signal.
- relatively high frequency noise such as the muscle noise source 12 b and/or the EMI source 12 d may be estimated by calculating the peak-to-peak average for the noise curve.
- relatively low frequency noise such as the motion artifact noise source 12 c might be estimated by rejecting outlier data in the isolated noise and determining the area under the resulting curve.
- the illustrated qualitative and quantitative analyses may also be conducted for each of the plurality of noise sources.
- a plurality of qualitative ratings may be obtained, wherein the plurality of qualitative ratings correspond to the plurality of noise sources.
- a plurality of SNRs may be obtained for the plurality of noise sources.
- the individual qualitative ratings QR 1 , QR 2 , . . .
- the individual qualitative ratings may be combined using a scoring function to arrive at an overall qualitative rating (OQR) in terms of Good, Fair or Poor.
- illustrated block 48 provides for determining an OQR for the physiological signal.
- Block 48 may also determine an overall quality level (OQL) for the physiological signal, wherein the OQL may be based on both the individual qualitative analyses (QR 1 , QR 2 , . . . ) and the individual quantitative analyses (SNR 1 , SNR 2 , . . . ). More particularly, a dynamic weighting function may combine the individual SNRs into a single value (e.g., ranging from zero to ten). The weights in the weighting function may change dynamically if a certain noise type is present in excessive quantity to tilt the physiological signal quality to unacceptable levels.
- OQL overall quality level
- the weighting function may adjust the weight of this particular noise type relative to other noise types so that due consideration is given to a single excessive noise type over mild-to-moderate amounts of multiple noise types that may be acceptable.
- the dynamic weighting function may be implemented so that OQL is a function of,
- Block 48 may also provide for storing the de-noised physiological signal as well as the qualitative and quantitative information associated with the physiological signal (e.g., individual QRs, OQR, OQL, etc.) for later use.
- FIG. 4 shows a weighting curve 50 that may be used to assign weights to individual noise types.
- weighting curve 50 may be used to assign weights to individual noise types.
- its associated weight may sharply fall toward zero so as to significantly reduce the SNR contribution of that noise type to the OQL.
- Such an approach may effectively amplify the presence of a noise type in excessive amounts, by significantly reducing the OQL.
- a determination may be made at block 52 as to whether a quality condition has been satisfied.
- the quality condition may specify, for example, that no noise type has an individual QR of “Poor”, the OQR is either “Good” or “Fair”, the OQL is above a certain threshold (e.g., 5 out of 10), etc., or any combination thereof.
- illustrated block 54 determines whether a maximum number of readings (e.g., three) has been reached. If not, a user prompt may be generated at block 56 . The user prompt may request one or more additional readings (e.g., “Please take another ECG reading”).
- the user prompt may also include a recommendation that is tailored to one or more of the plurality of noise sources. For example, in the case of baseline wander noise, the patient might be asked to hold the device lightly and with uniform pressure. In the case of excessive muscle tremor noise, the patient may be asked to relax and support his or her hands. In the case of motion artifact noise, the patient might be asked to remain still or avoid too much chest movement during breathing. In the case of excessive power main interference or EMI, the patient may be asked to change locations and/or power off nearby devices. Other noise type-specific recommendations may also be made.
- the illustrated method 26 may be repeated to obtain a plurality of physiological signals associated with a corresponding plurality of readings, and conduct the qualitative and quantitative analyses for each of the plurality of physiological signals.
- the resulting physiological signals and associated qualitative and quantitative data may be stored for later use, as already noted.
- block 58 may select the best physiological signal based on the qualitative and quantitative analysis results, wherein the selected best physiological signal (and associated qualitative and quantitative data) is reported to a remote location at illustrated block 60 .
- FIG. 5 shows a logic architecture 51 ( 51 a - 51 g ) to evaluate physiological signals in a home health setting.
- a sensor interface 51 a receives a physiological signal from a sensor configuration associated with a mobile device and a qualitative module 51 b conducts a qualitative analysis for each of a plurality of noise sources in the physiological signal to obtain a corresponding plurality of qualitative ratings.
- a selection module 51 c may use at least the plurality of qualitative ratings to determine whether to report the physiological signal to a remote location.
- the architecture 51 also includes a quantitative module 51 d to conduct a quantitative analysis for each of the plurality of noise sources to obtain an overall quality level, wherein the overall quality level may also be used to determine whether to report the physiological signal to the remote location. More particularly, the quantitative module 51 d may assign weights to signal to noise ratios associated with the plurality of noise sources based on the plurality of qualitative ratings.
- the qualitative module 51 b may combine the plurality of qualitative ratings into an overall qualitative rating, wherein the overall qualitative rating is to be used to determine whether to report the physiological signal to the remote location.
- the illustrated architecture 51 also includes a noise extraction module 51 e to filter, for each of the plurality of noise sources, the physiological signal, and a noise estimation module 51 f to conduct a noise estimation for the filtered physiological signal.
- the architecture 51 may also include a user interface (UI) to generate a user prompt if a quality condition is not satisfied.
- the user prompt may request one or more additional readings and/or include a recommendation that is tailored to one or more of the plurality of noise sources.
- the platform 62 may be part of a mobile device having computing functionality (e.g., PDA, laptop, smart tablet), communications functionality (e.g., wireless smart phone), imaging functionality, media playing functionality (e.g., smart television/TV), or any combination thereof (e.g., mobile Internet device/MID).
- computing functionality e.g., PDA, laptop, smart tablet
- communications functionality e.g., wireless smart phone
- imaging functionality e.g., smart television/TV
- media playing functionality e.g., smart television/TV
- mobile Internet device/MID e.g., mobile Internet device/MID
- the platform 62 includes a processor 64 , an integrated memory controller (IMC) 66 , an input output (I 0 ) module 68 , system memory 70 , a network controller 72 , a sensor configuration 74 , mass storage 76 (e.g., optical disk, hard disk drive/HDD, flash memory), one or more user interface (UI) devices 82 and a battery 80 to supply power to the platform 62 .
- the processor 64 may include a core region with one or several processor cores 78 .
- the illustrated IO module 68 functions as a host controller and communicates with the network controller 72 , which could provide off-platform communication functionality for a wide variety of purposes such as, for example, cellular telephone (e.g., Wideband Code Division Multiple Access/W-CDMA (Universal Mobile Telecommunications System/UMTS), CDMA2000 (IS-856/IS-2000), etc.), WiFi (Wireless Fidelity, e.g., Institute of Electrical and Electronics Engineers/IEEE 802.11-2007, Wireless Local Area Network/LAN Medium Access Control (MAC) and Physical Layer (PHY) Specifications), 4G LTE (Fourth Generation Long Term Evolution), Bluetooth (e.g., IEEE 802.15.1-2005, Wireless Personal Area Networks), WiMax (e.g., IEEE 802.16-2004, LAN/MAN Broadband Wireless LANS), Global Positioning System (GPS), spread spectrum (e.g., 900 MHz), and other radio frequency (RF)
- W-CDMA Universal Mobile Telecommunications System/UMTS
- CDMA2000 IS
- the IO module 68 may also include one or more wireless hardware circuit blocks to support such functionality. Although the processor 64 and IO module 68 are illustrated as separate blocks, the processor 64 and IO module 68 may be implemented as a system on chip (SoC) on the same semiconductor die.
- SoC system on chip
- the system memory 70 may include, for example, double data rate (DDR) synchronous dynamic random access memory (SDRAM, e.g., DDR3 SDRAM JEDEC Standard JESD79-3C, April 2008) modules.
- DDR double data rate
- SDRAM synchronous dynamic random access memory
- the modules of the system memory 70 may be incorporated into a single inline memory module (SIMM), dual inline memory module (DIMM), small outline DIMM (SODIMM), and so forth.
- the illustrated cores 78 execute logic 84 to evaluate physiological signals in home health settings as already described with respect to FIGS. 4 and 5 .
- the logic 84 may receive physiological signals from the sensor configuration 74 , conduct a qualitative analysis for each of a plurality of noise sources in the physiological signals to obtain a corresponding plurality of qualitative ratings, and use at least the plurality of qualitative ratings to determine whether to report the physiological signals to a remote location.
- the logic 84 may also conduct a quantitative analysis for each of the plurality of noise sources to obtain an overall quality level, wherein the overall quality level is also used to determine whether to report the physiological signals to the remote location.
- User prompts for additional readings may be presented to the patient via the UI devices 82 , which may include a display, speaker, and so forth.
- Example 1 may include a mobile device to evaluate physiological signals, comprising a battery to provide power to the mobile device, a sensor configuration and a sensor interface to receive a physiological signal from the sensor configuration.
- the mobile device may also include a qualitative module to conduct a qualitative analysis for each of a plurality of noise sources in the physiological signal to obtain a corresponding plurality of qualitative ratings, and a selection module to use at least the plurality of qualitative ratings to determine whether to report the physiological signal to a remote location.
- Example 2 may include the mobile device of Example 1, further including a quantitative module to conduct a quantitative analysis for each of the plurality of noise sources to obtain an overall quality level, wherein the overall quality level is to be used to determine whether to report the physiological signal to the remote location.
- Example 3 may include the mobile device of Example 2, wherein the quantitative module is to assign weights to signal to noise ratios associated with the plurality of noise sources based on the plurality of qualitative ratings.
- Example 4 may include the mobile device of Example 1, wherein the qualitative module is to combine the plurality of qualitative ratings into an overall qualitative rating, and wherein the overall qualitative rating is to be used to determine whether to report the physiological signal to the remote location.
- Example 5 may include the mobile device of Example 1, further including a user interface to generate a user prompt if a quality condition is not satisfied, wherein the user prompt is to request one or more additional readings and include a recommendation that is tailored to one or more of the plurality of noise sources.
- Example 6 may include the mobile device of any one of Examples 1 to 5, further including a noise extraction module to filter, for each of the plurality of noise sources, the physiological signal, and a noise estimation module to conduct a noise estimation for the filtered physiological signal.
- Example 7 may include an apparatus to evaluate physiological signals, comprising a sensor interface to receive a physiological signal from a sensor configuration associated with a mobile device, a qualitative module to conduct a qualitative analysis for each of a plurality of noise sources in the physiological signal to obtain a corresponding plurality of qualitative ratings, and a selection module to use at least the plurality of qualitative ratings to determine whether to report the physiological signal to a remote location.
- a sensor interface to receive a physiological signal from a sensor configuration associated with a mobile device
- a qualitative module to conduct a qualitative analysis for each of a plurality of noise sources in the physiological signal to obtain a corresponding plurality of qualitative ratings
- a selection module to use at least the plurality of qualitative ratings to determine whether to report the physiological signal to a remote location.
- Example 8 may include the apparatus of Example 7, further including a quantitative module to conduct a quantitative analysis for each of the plurality of noise sources to obtain an overall quality level, wherein the overall quality level is to be used to determine whether to report the physiological signal to the remote location.
- Example 9 may include the apparatus of Example 8, wherein the quantitative module is to assign weights to signal to noise ratios associated with the plurality of noise sources based on the plurality of qualitative ratings.
- Example 10 may include the apparatus of Example 7, wherein the qualitative module is to combine the plurality of qualitative ratings into an overall qualitative rating, and wherein the overall qualitative rating is to be used to determine whether to report the physiological signal to the remote location.
- Example 11 may include the apparatus of Example 7, further including a user interface to generate a user prompt if a quality condition is not satisfied, wherein the user prompt is to request one or more additional readings and include a recommendation that is tailored to one or more of the plurality of noise sources.
- Example 12 may include the apparatus of any one of Examples 7 to 11, further including a noise extraction module to filter, for each of the plurality of noise sources, the physiological signal, and a noise estimation module to conduct a noise estimation for the filtered physiological signal.
- Example 13 may include a method of evaluating physiological signals, comprising receiving a physiological signal from a sensor configuration associated with a mobile device, conducting a qualitative analysis for each of a plurality of noise sources in the physiological signal to obtain a corresponding plurality of qualitative ratings, and using at least the plurality of qualitative ratings to determine whether to report the physiological signal to a remote location.
- Example 14 may include the method of Example 13, further including conducting a quantitative analysis for each of the plurality of noise sources to obtain an overall quality level, wherein the overall quality level is used to determine whether to report the physiological signal to the remote location.
- Example 15 may include the method of Example 14, further including assigning weights to signal to noise ratios associated with the plurality of noise sources based on plurality of qualitative ratings.
- Example 16 may include the method of Example 13, further including combining the plurality of qualitative ratings into an overall qualitative rating, wherein the overall qualitative rating is used to determine whether to report the physiological signal to the remote location.
- Example 17 may include the method of Example 13, further including generating a user prompt if a quality condition is not satisfied, wherein the user prompt requests or more additional readings and includes a recommendation that is tailored to one or more of the plurality of noise sources.
- Example 18 may include the method of any one of Examples 13 to 17, further including filtering, for each of the plurality of noise sources, the physiological signal, and conducting a noise estimation for the filtered physiological signal.
- Example 19 may include at least one computer readable storage medium comprising a set of instructions which, if executed by a mobile device, causes the mobile device to perform the method of any one of Examples 13 to 18.
- Example 20 may include an apparatus to evaluate physiological signals, comprising means for performing the method of any one of Examples 13 to 18.
- techniques described herein may therefore automatically assess physiological signal quality by measuring contributions due to multiple types of noise. Additionally, rather than relying on a single noise type, techniques may synthesize a holistic signal quality assessment. Moreover, since noise types may be separately extracted and quantified, it is also possible to point out the exact cause of the noise to the end user/patient. Such an approach may enable the patient to precisely correct the cause of the noise in successive measurements. In addition, a dynamic weighting approach may bias analysis results so that excessive contamination from a single noise source (which is typically unacceptable), over mild/moderate contamination from multiple noise sources (which may be acceptable). Techniques may also enhance performance by selecting the best quality metrics from a set of re-measurement results.
- the likelihood of generating clinically acceptable physiological signals may be improved because only those physiological signals with clinically acceptable quality may be sent to the healthcare network for interpretation by a medical professional.
- Turnaround time for desired medical advice may also be significantly reduced under the techniques described herein.
- the techniques may also enable individuals with little or no medical or technical training to self-measure their own physiological condition in remote/home settings. Indeed, various risk-mitigation requirements associated with medical standards may be satisfied using the techniques described herein.
- Embodiments of the present invention are applicable for use with all types of semiconductor integrated circuit (“IC”) chips.
- IC semiconductor integrated circuit
- Examples of these IC chips include but are not limited to processors, controllers, chipset components, programmable logic arrays (PLAs), memory chips, network chips, systems on chip (SoCs), SSD/NAND controller ASICs, and the like.
- PLAs programmable logic arrays
- SoCs systems on chip
- SSD/NAND controller ASICs solid state drive/NAND controller ASICs
- signal conductor lines are represented with lines. Some may be different, to indicate more constituent signal paths, have a number label, to indicate a number of constituent signal paths, and/or have arrows at one or more ends, to indicate primary information flow direction. This, however, should not be construed in a limiting manner.
- Any represented signal lines may actually comprise one or more signals that may travel in multiple directions and may be implemented with any suitable type of signal scheme, e.g., digital or analog lines implemented with differential pairs, optical fiber lines, and/or single-ended lines.
- Example sizes/models/values/ranges may have been given, although embodiments of the present invention are not limited to the same. As manufacturing techniques (e.g., photolithography) mature over time, it is expected that devices of smaller size could be manufactured.
- well known power/ground connections to IC chips and other components may or may not be shown within the figures, for simplicity of illustration and discussion, and so as not to obscure certain aspects of the embodiments of the invention.
- arrangements may be shown in block diagram form in order to avoid obscuring embodiments of the invention, and also in view of the fact that specifics with respect to implementation of such block diagram arrangements are highly dependent upon the platform within which the embodiment is to be implemented, i.e., such specifics should be well within purview of one skilled in the art.
- Coupled may be used herein to refer to any type of relationship, direct or indirect, between the components in question, and may apply to electrical, mechanical, fluid, optical, electromagnetic, electromechanical or other connections.
- first”, second”, etc. are used herein only to facilitate discussion, and carry no particular temporal or chronological significance unless otherwise indicated.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Signal Processing (AREA)
- Artificial Intelligence (AREA)
- Physiology (AREA)
- Theoretical Computer Science (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Multimedia (AREA)
- Biodiversity & Conservation Biology (AREA)
- Computational Linguistics (AREA)
- Data Mining & Analysis (AREA)
- Evolutionary Computation (AREA)
- Computing Systems (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Mathematical Physics (AREA)
- Software Systems (AREA)
- Computer Networks & Wireless Communication (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Description
TABLE I | |
Individual Qualitative | |
Rating Criteria | Rating (QR) |
Noise type is not visually apparent in | Good |
the physiological signal | |
Noise type is present in the | Fair |
physiological signal and is visually apparent | |
in moderate amounts, but the physiological | |
signal may still be visually interpreted for | |
diagnosis | |
Noise type is present in the | Poor |
physiological signal in excessive amounts | |
such that the physiological signal may not be | |
visually interpreted for diagnosis | |
Claims (23)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/418,352 US11721435B2 (en) | 2013-06-12 | 2019-05-21 | Automated quality assessment of physiological signals |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2556/CHE/2013 | 2013-06-12 | ||
ININ2556/CHE/2013 | 2013-06-12 | ||
IN2556CH2013 | 2013-06-12 | ||
PCT/US2014/041334 WO2014200856A1 (en) | 2013-06-12 | 2014-06-06 | Automated quality assessment of physiological signals |
US201514780465A | 2015-09-25 | 2015-09-25 | |
US16/418,352 US11721435B2 (en) | 2013-06-12 | 2019-05-21 | Automated quality assessment of physiological signals |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/780,465 Continuation US10296835B2 (en) | 2013-06-12 | 2014-06-06 | Automated quality assessment of physiological signals |
PCT/US2014/041334 Continuation WO2014200856A1 (en) | 2013-06-12 | 2014-06-06 | Automated quality assessment of physiological signals |
Publications (3)
Publication Number | Publication Date |
---|---|
US20200050948A1 US20200050948A1 (en) | 2020-02-13 |
US20200210861A9 US20200210861A9 (en) | 2020-07-02 |
US11721435B2 true US11721435B2 (en) | 2023-08-08 |
Family
ID=52022678
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/780,465 Active 2036-08-16 US10296835B2 (en) | 2013-06-12 | 2014-06-06 | Automated quality assessment of physiological signals |
US16/418,352 Active 2036-04-09 US11721435B2 (en) | 2013-06-12 | 2019-05-21 | Automated quality assessment of physiological signals |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/780,465 Active 2036-08-16 US10296835B2 (en) | 2013-06-12 | 2014-06-06 | Automated quality assessment of physiological signals |
Country Status (7)
Country | Link |
---|---|
US (2) | US10296835B2 (en) |
EP (2) | EP3008686A4 (en) |
JP (1) | JP6144412B2 (en) |
KR (1) | KR101821967B1 (en) |
CN (1) | CN105210107B (en) |
TW (1) | TWI518629B (en) |
WO (1) | WO2014200856A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0671197B2 (en) | 1989-09-20 | 1994-09-07 | 三洋電機株式会社 | Tuning device |
TWI518629B (en) | 2013-06-12 | 2016-01-21 | 英特爾股份有限公司 | Automated quality assessment of physiological signals |
EP3416555A1 (en) | 2016-02-17 | 2018-12-26 | Nuralogix Corporation | System and method for detecting physiological state |
EP4008251A1 (en) | 2016-09-06 | 2022-06-08 | Vigor Medical Systems, Inc. | Digital treatment or rehabilitation program system |
TWI598073B (en) | 2016-12-15 | 2017-09-11 | 財團法人工業技術研究院 | Physiological signal measurement method and physiological signal measurement device |
WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
US11471083B2 (en) | 2017-10-24 | 2022-10-18 | Nuralogix Corporation | System and method for camera-based stress determination |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
CN110290746B (en) * | 2017-12-30 | 2022-04-22 | 深圳迈瑞生物医疗电子股份有限公司 | High-frequency radio frequency interference removing device and method |
US11318277B2 (en) | 2017-12-31 | 2022-05-03 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
WO2020056418A1 (en) | 2018-09-14 | 2020-03-19 | Neuroenhancement Lab, LLC | System and method of improving sleep |
US20200205739A1 (en) * | 2018-12-26 | 2020-07-02 | Analytics For Life Inc. | Method and system for automated quantification of signal quality |
KR102773553B1 (en) * | 2019-02-01 | 2025-02-25 | 삼성전자주식회사 | Heartbeat index determination apparatus and method |
CN109893121B (en) * | 2019-03-26 | 2021-11-05 | 深圳理邦智慧健康发展有限公司 | Electrocardiosignal acquisition method, electrocardiosignal acquisition device, electrocardiosignal acquisition terminal and computer-readable storage medium |
US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
TWI782282B (en) * | 2020-06-08 | 2022-11-01 | 宏智生醫科技股份有限公司 | Brain wave monitoring system and method thereof |
TWI832075B (en) * | 2021-08-02 | 2024-02-11 | 英商盛世有限公司 | Systems and methods for tremor management |
KR102677449B1 (en) * | 2021-10-14 | 2024-06-20 | 삼성전자주식회사 | Method for evaluating of bio-signal and apparatus for estimating bio-information |
Citations (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1211152A (en) | 1916-05-12 | 1917-01-02 | Sterling P Hickerson | Collapsible chicken-coop. |
US6229856B1 (en) * | 1997-04-14 | 2001-05-08 | Masimo Corporation | Method and apparatus for demodulating signals in a pulse oximetry system |
US20030233129A1 (en) | 2002-06-11 | 2003-12-18 | Matos Jeffrey A. | System for cardiac resuscitation |
US20070043585A1 (en) | 2005-08-17 | 2007-02-22 | Matos Jeffrey A | Emergency management system |
US20070063850A1 (en) | 2005-09-13 | 2007-03-22 | Devaul Richard W | Method and system for proactive telemonitor with real-time activity and physiology classification and diary feature |
US20070299473A1 (en) | 2003-06-11 | 2007-12-27 | Matos Jeffrey A | System for cardiac resuscitation |
US20080091089A1 (en) | 2006-10-12 | 2008-04-17 | Kenneth Shane Guillory | Single use, self-contained surface physiological monitor |
US20080091090A1 (en) | 2006-10-12 | 2008-04-17 | Kenneth Shane Guillory | Self-contained surface physiological monitor with adhesive attachment |
US20080146892A1 (en) | 2006-12-19 | 2008-06-19 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
JP2008168073A (en) | 2007-01-15 | 2008-07-24 | Fukuda Denshi Co Ltd | Biological information processing apparatus and biological information processing method |
US20080194925A1 (en) | 2005-05-06 | 2008-08-14 | Koninklijke Philips Electronics N. V. | Wireless Medical Monitoring Device |
US20090048497A1 (en) | 2007-08-13 | 2009-02-19 | Cheetah Medical Ltd. | Dynamically variable filter |
US20090082691A1 (en) | 2007-09-26 | 2009-03-26 | Medtronic, Inc. | Frequency selective monitoring of physiological signals |
CN101504696A (en) | 2008-02-05 | 2009-08-12 | 周常安 | Interactive physiological analysis method |
US20100022903A1 (en) | 2008-07-28 | 2010-01-28 | Sitzman David A | System and method for signal quality indication and false alarm reduction in ecg monitoring systems |
WO2010111651A1 (en) | 2009-03-27 | 2010-09-30 | Cardionet, Inc. | Ambulatory and centralized processing of a physiological signal |
US20100332173A1 (en) | 2009-06-30 | 2010-12-30 | Nellcor Puritan Bennett Ireland | Systems and methods for assessing measurements in physiological monitoring devices |
CN101980228A (en) | 2010-09-01 | 2011-02-23 | 张辉 | Human body information monitoring and processing system and method |
TW201112179A (en) | 2009-08-19 | 2011-04-01 | Chang-Ming Yang | Object for detecting physiology and posture status |
TW201134252A (en) | 2009-11-24 | 2011-10-01 | Qualcomm Inc | Method and apparatus for facilitating a layered cell search for long term evolution systems |
TWI353242B (en) | 2007-11-02 | 2011-12-01 | Univ Nat Taiwan | Rapid method for analyzing bio-signal instantaneou |
CN102270264A (en) | 2010-06-04 | 2011-12-07 | 中国科学院深圳先进技术研究院 | Physiological signal quality evaluation system and method |
US20120108989A1 (en) | 2009-07-06 | 2012-05-03 | Heard Systems Pty Ltd | Non-invasively measuring physiological process |
US20120149996A1 (en) | 2002-10-09 | 2012-06-14 | Stivoric John M | Method and apparatus for providing derived glucose information utilizing physiological and/or contextual parameters |
US20130096450A1 (en) | 2011-10-18 | 2013-04-18 | General Electric Company | System and method of quality analysis in acquisition of ambulatory electrocardiography device data |
WO2013066642A1 (en) | 2011-10-19 | 2013-05-10 | Scanadu Incorporated | Automated personal medical diagnostic system, method, and arrangement |
US20130278430A1 (en) * | 2009-07-24 | 2013-10-24 | Cercacor Laboratories, Inc. | Interference detector for patient monitor |
US20140107493A1 (en) | 2012-06-22 | 2014-04-17 | Fitbit, Inc. | Portable Biometric Monitoring Devices and Methods of Operating Same |
US20140378787A1 (en) | 2012-06-22 | 2014-12-25 | Fitbit, Inc. | Biometric monitoring device with heart rate measurement activated by a single user-gesture |
US20150335288A1 (en) | 2013-06-06 | 2015-11-26 | Tricord Holdings, Llc | Modular physiologic monitoring systems, kits, and methods |
US20160055415A1 (en) | 2013-06-12 | 2016-02-25 | Intel Corporation | Automated quality assessment of physiological signals |
US20170359635A1 (en) | 2014-09-27 | 2017-12-14 | Valencell, Inc. | Methods for improving signal quality in wearable biometric monitoring devices |
-
2014
- 2014-05-26 TW TW103118238A patent/TWI518629B/en active
- 2014-06-06 EP EP14811376.4A patent/EP3008686A4/en not_active Ceased
- 2014-06-06 EP EP20153449.2A patent/EP3660779B1/en active Active
- 2014-06-06 CN CN201480027219.9A patent/CN105210107B/en active Active
- 2014-06-06 JP JP2016514172A patent/JP6144412B2/en active Active
- 2014-06-06 WO PCT/US2014/041334 patent/WO2014200856A1/en active Application Filing
- 2014-06-06 KR KR1020157032275A patent/KR101821967B1/en active Active
- 2014-06-06 US US14/780,465 patent/US10296835B2/en active Active
-
2019
- 2019-05-21 US US16/418,352 patent/US11721435B2/en active Active
Patent Citations (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1211152A (en) | 1916-05-12 | 1917-01-02 | Sterling P Hickerson | Collapsible chicken-coop. |
US6229856B1 (en) * | 1997-04-14 | 2001-05-08 | Masimo Corporation | Method and apparatus for demodulating signals in a pulse oximetry system |
US20030233129A1 (en) | 2002-06-11 | 2003-12-18 | Matos Jeffrey A. | System for cardiac resuscitation |
US20120149996A1 (en) | 2002-10-09 | 2012-06-14 | Stivoric John M | Method and apparatus for providing derived glucose information utilizing physiological and/or contextual parameters |
US8180457B2 (en) | 2003-06-11 | 2012-05-15 | Matos Jeffrey A | System for cardiac resuscitation |
US7769465B2 (en) | 2003-06-11 | 2010-08-03 | Matos Jeffrey A | System for cardiac resuscitation |
US20070299473A1 (en) | 2003-06-11 | 2007-12-27 | Matos Jeffrey A | System for cardiac resuscitation |
US20100324612A1 (en) | 2003-06-11 | 2010-12-23 | Matos Jeffrey A | System for cardiac resuscitation |
US7840277B2 (en) | 2003-06-11 | 2010-11-23 | Matos Jeffrey A | Emergency management system |
US20090276013A1 (en) | 2003-06-11 | 2009-11-05 | Matos Jeffrey A | Emergency management system |
US20080194925A1 (en) | 2005-05-06 | 2008-08-14 | Koninklijke Philips Electronics N. V. | Wireless Medical Monitoring Device |
JP2008543127A (en) | 2005-05-06 | 2008-11-27 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Wireless medical monitoring device |
US20070043585A1 (en) | 2005-08-17 | 2007-02-22 | Matos Jeffrey A | Emergency management system |
US20070063850A1 (en) | 2005-09-13 | 2007-03-22 | Devaul Richard W | Method and system for proactive telemonitor with real-time activity and physiology classification and diary feature |
US20080091090A1 (en) | 2006-10-12 | 2008-04-17 | Kenneth Shane Guillory | Self-contained surface physiological monitor with adhesive attachment |
US20080091089A1 (en) | 2006-10-12 | 2008-04-17 | Kenneth Shane Guillory | Single use, self-contained surface physiological monitor |
US20180242859A1 (en) | 2006-12-19 | 2018-08-30 | Valencell, Inc. | Physiological monitoring methods |
US20120226111A1 (en) | 2006-12-19 | 2012-09-06 | Leboeuf Steven Francis | Physiological and environmental monitoring methods |
US20140287833A1 (en) | 2006-12-19 | 2014-09-25 | Valencell, Inc. | Methods of generating gaming characters using physiological and/or environmental information |
US20140288396A1 (en) | 2006-12-19 | 2014-09-25 | Valencell, Inc. | Apparatus, systems, and methods for measuring environmental exposure and physiological response thereto |
US20150141772A1 (en) | 2006-12-19 | 2015-05-21 | Valencell, Inc. | Physiological Monitoring Methods |
US20160317049A1 (en) | 2006-12-19 | 2016-11-03 | Valencell, Inc. | Apparatus, Systems, and Methods for Measuring Environmental Exposure and Physiological Response Thereto |
US20120226112A1 (en) | 2006-12-19 | 2012-09-06 | Leboeuf Steven Francis | Physiological and environmental monitoring systems and methods |
US20120203081A1 (en) | 2006-12-19 | 2012-08-09 | Leboeuf Steven Francis | Physiological and environmental monitoring apparatus and systems |
US20120197737A1 (en) | 2006-12-19 | 2012-08-02 | Leboeuf Steven Francis | Targeted advertising systems and methods |
US20140275855A1 (en) | 2006-12-19 | 2014-09-18 | Valencell, Inc. | Systems and methods for generating targeted advertising |
US20180242860A1 (en) | 2006-12-19 | 2018-08-30 | Valencell, Inc. | Wearable monitoring devices |
US20110098112A1 (en) | 2006-12-19 | 2011-04-28 | Leboeuf Steven Francis | Physiological and Environmental Monitoring Systems and Methods |
US20110106627A1 (en) | 2006-12-19 | 2011-05-05 | Leboeuf Steven Francis | Physiological and Environmental Monitoring Systems and Methods |
US20080146892A1 (en) | 2006-12-19 | 2008-06-19 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
JP2008168073A (en) | 2007-01-15 | 2008-07-24 | Fukuda Denshi Co Ltd | Biological information processing apparatus and biological information processing method |
US20090048497A1 (en) | 2007-08-13 | 2009-02-19 | Cheetah Medical Ltd. | Dynamically variable filter |
US20090082691A1 (en) | 2007-09-26 | 2009-03-26 | Medtronic, Inc. | Frequency selective monitoring of physiological signals |
CN101848677A (en) | 2007-09-26 | 2010-09-29 | 麦德托尼克公司 | Frequency selective monitoring of physiological signals |
TWI353242B (en) | 2007-11-02 | 2011-12-01 | Univ Nat Taiwan | Rapid method for analyzing bio-signal instantaneou |
CN101504696A (en) | 2008-02-05 | 2009-08-12 | 周常安 | Interactive physiological analysis method |
JP2010029656A (en) | 2008-07-28 | 2010-02-12 | General Electric Co <Ge> | System and method for signal quality indication and false alarm reduction in ecg monitoring system |
US20100022903A1 (en) | 2008-07-28 | 2010-01-28 | Sitzman David A | System and method for signal quality indication and false alarm reduction in ecg monitoring systems |
US8805482B2 (en) | 2008-07-28 | 2014-08-12 | General Electric Conpany | System and method for signal quality indication and false alarm reduction in ECG monitoring systems |
US20170367575A1 (en) | 2009-03-27 | 2017-12-28 | Braemar Manufacturing, Llc | Ambulatory and centralized processing of a physiological signal |
US20100249625A1 (en) | 2009-03-27 | 2010-09-30 | Cardionet, Inc. | Ambulatory and Centralized Processing of a Physiological Signal |
WO2010111651A1 (en) | 2009-03-27 | 2010-09-30 | Cardionet, Inc. | Ambulatory and centralized processing of a physiological signal |
US20100332173A1 (en) | 2009-06-30 | 2010-12-30 | Nellcor Puritan Bennett Ireland | Systems and methods for assessing measurements in physiological monitoring devices |
US20120108989A1 (en) | 2009-07-06 | 2012-05-03 | Heard Systems Pty Ltd | Non-invasively measuring physiological process |
US20130278430A1 (en) * | 2009-07-24 | 2013-10-24 | Cercacor Laboratories, Inc. | Interference detector for patient monitor |
TW201112179A (en) | 2009-08-19 | 2011-04-01 | Chang-Ming Yang | Object for detecting physiology and posture status |
TW201134252A (en) | 2009-11-24 | 2011-10-01 | Qualcomm Inc | Method and apparatus for facilitating a layered cell search for long term evolution systems |
CN102270264A (en) | 2010-06-04 | 2011-12-07 | 中国科学院深圳先进技术研究院 | Physiological signal quality evaluation system and method |
US20130116580A1 (en) | 2010-06-04 | 2013-05-09 | Shenzhen Institute Of Advanced Technology Chinese Academy Of Sciences | System for quality assessment of physiological signals and method thereof |
CN101980228A (en) | 2010-09-01 | 2011-02-23 | 张辉 | Human body information monitoring and processing system and method |
US8489182B2 (en) | 2011-10-18 | 2013-07-16 | General Electric Company | System and method of quality analysis in acquisition of ambulatory electrocardiography device data |
US20130096450A1 (en) | 2011-10-18 | 2013-04-18 | General Electric Company | System and method of quality analysis in acquisition of ambulatory electrocardiography device data |
WO2013066642A1 (en) | 2011-10-19 | 2013-05-10 | Scanadu Incorporated | Automated personal medical diagnostic system, method, and arrangement |
US20140257058A1 (en) | 2011-10-19 | 2014-09-11 | Scanadu Incorporated | Automated personal medical diagnostic system, method, and arrangement |
US20140107493A1 (en) | 2012-06-22 | 2014-04-17 | Fitbit, Inc. | Portable Biometric Monitoring Devices and Methods of Operating Same |
US20140378787A1 (en) | 2012-06-22 | 2014-12-25 | Fitbit, Inc. | Biometric monitoring device with heart rate measurement activated by a single user-gesture |
US20170135636A1 (en) | 2012-06-22 | 2017-05-18 | Fitbit, Inc. | Portable biometric monitoring devices and methods of operating same |
US20150335288A1 (en) | 2013-06-06 | 2015-11-26 | Tricord Holdings, Llc | Modular physiologic monitoring systems, kits, and methods |
US20160055415A1 (en) | 2013-06-12 | 2016-02-25 | Intel Corporation | Automated quality assessment of physiological signals |
US10296835B2 (en) | 2013-06-12 | 2019-05-21 | Intel Corporation | Automated quality assessment of physiological signals |
US20170359635A1 (en) | 2014-09-27 | 2017-12-14 | Valencell, Inc. | Methods for improving signal quality in wearable biometric monitoring devices |
Non-Patent Citations (25)
Title |
---|
Blanco-Velasco et al., "ECG signal Denoising and Baseline Wander Correction Based on the Empirical Mode Decompostion," Computers in Biology and Medicine, 2008, vol. 38, pp. 1-13, 13 pages. |
Chinese State Intellectual Patent Office, "First Office Action," issued in connection with Chinese Application No. 201480027219.9, dated Jun. 1, 2018, 8 pages. |
Chinese State Intellectual Patent Office, "Notice on Grant of Patent," issued in connection with Chinese Patent Application No. 201480027219.9, dated Aug. 20, 2019, 4 pages (includes English translation). |
Chinese State Intellectual Patent Office, "Second Office Action," issued in connection with Chinese Patent Application No. 201480027219.9, dated Feb. 20, 2019, 6 pages. |
European Patent Office, "Communication pursuant to Article 94(3) EPC," issued in connection with European Patent Application 20153449.2, dated Dec. 9, 2021, 6 pages. |
European Patent Office, "Communication pursuant to Article 94(3) EPC," issued in connection with European Patent Application No. 14811376.4, dated Jul. 24, 2018, 6 pages. |
European Patent Office, "Decision to Refuse European Patent Application," issued in connection with European Patent Application No. 14811376.4, dated Jul. 15, 2020, 20 pages. |
European Patent Office, "Extended European Search Report," issued in connection with European Patent Application No. 20153449.2, dated Mar. 31, 2020, 9 pages. |
European Patent Office, "Summons to attend oral proceedings pursuant to Rule 115(1) EPC," issued in connection with European Patent Application No. 14811376.4, dated Jul. 24, 2019, 9 pages. |
European Patent Office, European Search Report for European Patent Application No. 14780465-4, dated Jan. 23, 2017, 7 pages. (Document not provided. Copy provided in parent U.S. Appl. No. 14/780,465). |
India Patent Office, Office Action for Indian Patent Application No. 2556/CHE/2013, dated Oct. 26, 2018, 5 pages. (Document not provided. Copy provided in parent U.S. Appl. No. 14/780,465). |
Indian Patent Office, "Notice of Grant," issued in connection with Indian Patent Application No. 2556/CHE/2013, dated Sep. 10, 2019, 2 pages. |
International Bureau, "International Preliminary Report on Patentability," issued in connection with International Patent Application No. PCT/US2014/041334, dated Dec. 15, 2015, 6 pages. |
International Searching Authority, "International Search Report and Written Opinion," issued in connection with International Patent Application No. PCT/US2014/041334, dated Oct. 2, 2014, 8 pages. |
Japanese Patent Office, Office Action for Japanese Patent Application No. 2016-514172, dated Nov. 29, 2016, 6 pages including 3 pages of English Translation. (Document not provided. Copy provided in parent U.S. Appl. No. 14/780,465). |
Japenese Patent Office, "Decision to Grant," issued in connection with Japanese Patent Application No. 2016-514172, dated Apr. 11, 2017, 3 pages. |
Korean Intellectual Property Office, "Notice of Allowance," issued in connection with Korean Patent Application No. 20157032275, dated Oct. 20, 2017, 3 pages. (English translation provided). |
Korean Intellectual Property Office, "Notice of Final Rejection," issued in connection with Korean Patent Application No. 20157032275, dated Aug. 21, 2017, 6 pages (includes English translation). |
Korean Patent Office, Office Action for Korean Patent Application No. 2015-7032275, dated Feb. 7, 2017, 13 pages including 6 pages of English translation. (Document not provided. Copy provided in parent U.S. Appl. No. 14/780,465). |
Laciar et al. "An Improved Weighted Signal Averaging Method for High-Resolution ECG Signals," Computers in Cardiology, 2001, vol. 28, pp. 69-72, 4 pages. |
Leski et al., "ECG Baseline Wander and Powerline Interface Reduction Using Nonlinear Filter Bank," Signal Processing, 2005, vol. 85, pp. 781-793, 13 pages. |
Taiwanese Patent Office, "Notice of Allowance," issued in connection with Taiwanese Patent Application No. 103118238, dated Oct. 30, 2015, 2 pages. |
Taiwanese Patent Office, Office Action and Search Report for Taiwanese Patent Application No. 103118238, dated Jul. 6, 2015, 30 pages Including 15 pages of English translation. (Document not provided. Copy provided in parent U.S. Appl. No. 14/780,465). |
United States Patent and Trademark Office, "Non-Final Office Action," issued in connection with U.S. Appl. No. 14/780,465, dated Jul. 12, 2018, 8 pages. (Document not provided. Copy available in parent U.S. Appl. No. 14/780,465). |
United States Patent and Trademark Office, "Notice of Allowance," issued in connection with U.S. Appl. No. 14/780,465, dated Jan. 9, 2019, 5 pages. (Document not provided. Copy available in parent U.S. Appl. No. 14/780,465). |
Also Published As
Publication number | Publication date |
---|---|
US20200210861A9 (en) | 2020-07-02 |
EP3660779B1 (en) | 2024-09-25 |
US20200050948A1 (en) | 2020-02-13 |
CN105210107B (en) | 2019-11-19 |
US10296835B2 (en) | 2019-05-21 |
KR20150140822A (en) | 2015-12-16 |
EP3008686A4 (en) | 2017-02-22 |
EP3008686A1 (en) | 2016-04-20 |
EP3660779A1 (en) | 2020-06-03 |
TWI518629B (en) | 2016-01-21 |
TW201510917A (en) | 2015-03-16 |
US20160055415A1 (en) | 2016-02-25 |
WO2014200856A1 (en) | 2014-12-18 |
JP2016522037A (en) | 2016-07-28 |
KR101821967B1 (en) | 2018-01-25 |
JP6144412B2 (en) | 2017-06-07 |
CN105210107A (en) | 2015-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11721435B2 (en) | Automated quality assessment of physiological signals | |
Charlton et al. | Extraction of respiratory signals from the electrocardiogram and photoplethysmogram: technical and physiological determinants | |
AU2019202009A1 (en) | Multivariate residual-based health index for human health monitoring | |
US20220095930A1 (en) | Systems, devices, and methods for non-invasive cardiac monitoring | |
CN113712522A (en) | System and method for physiological feature derivation | |
US20160081627A1 (en) | System method for assessing fitness state via a mobile device | |
US11576601B2 (en) | Artifact identification in EEG measurements | |
EP3453321A1 (en) | Non-invasive method and system for estimating blood pressure from photoplethysmogram using statistical post-processing | |
JP6608527B2 (en) | Device, terminal and biometric information system | |
US20220192607A1 (en) | Apparatus and method for estimating blood pressure | |
JP2017536885A (en) | System and method for monitoring aortic pulse wave velocity and blood pressure | |
US8498696B2 (en) | Health monitoring device and human electric signal processing method | |
Baumann et al. | The pi-con methodology applied: Operator errors and preference tracking of a novel ubiquitous vital signs sensor and its user interface | |
CN105686832A (en) | Respiration-related signal measuring system and measuring method thereof | |
CN107920762A (en) | Device and method for calculating systolic blood pressure using pulse transit time | |
Paliwal et al. | Real time heart rate detection and heart rate variability calculation | |
TW201806550A (en) | Method of estimating respiratory rate and electronic apparatus thereof | |
US10751003B2 (en) | Reducing motion-related artifacts in optical measurements for vital signs monitoring | |
Vandendriessche et al. | Piloting the clinical value of wearable cardiorespiratory monitoring for people with cystic fibrosis | |
JP7289095B2 (en) | sleep education system, sleep education method and program | |
Boschi et al. | Optimized Cuffless Blood Pressure Measurement Using ECG, PPG and Linear Regression | |
WO2024197627A1 (en) | Heart-failure early-warning method and apparatus, and computer device and storage medium | |
Sureshkumar et al. | UPASANA: Diagnostic toolkit for ASHA worker | |
JP2023026124A (en) | Method and device for detecting biological signal and data processing apparatus | |
Velmurugan | Development of a Heart Rate Variability Measurement System using Embedded Electronics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
AS | Assignment |
Owner name: INTEL CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAXI, AMIT S.;REEL/FRAME:051520/0378 Effective date: 20140624 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
FEPP | Fee payment procedure |
Free format text: PETITION RELATED TO MAINTENANCE FEES GRANTED (ORIGINAL EVENT CODE: PTGR); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
AS | Assignment |
Owner name: TAHOE RESEARCH, LTD., IRELAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTEL CORPORATION;REEL/FRAME:061175/0176 Effective date: 20220718 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |